Our Highly regarded White Paper “Strategies and Innovations to Speed Up Drug Development into today’s dynamic market post COVID-19 )
1. Rare diseases: understanding the patient journey (manufacturingchemist.com)
2. Diversity in Clinical Trials: Going Beyond Why to How – ACRP (acrpnet.org)
3. Sertkaya, A; Wong, H. H.; Jessup, A; Beleche, T (2016). “Key cost drivers of pharmaceutical clinical trials in the United States.” Clinical Trials. 13 (2): 117–26. doi:10.1177/1740774515625964. PMID 26908540. S2CID 24308679.
Read Our Tool Kit and White Paper
Watch Our Videos
Strategic Guidance to Accelerate Drug Development
Innovative Solutions to increase Clinical Trial Diversity
CRO Selection and Management
Board Identification of Diverse Members
On Demand Key Talent
The Bios Health Group Story
Contact Us